Mohit Gupta, MD, and Trinity J. Bivalacqua, MD, PhD

All articles by Mohit Gupta, MD, and Trinity J. Bivalacqua, MD, PhD

Bladder Cancer

Developments in the Management of BCG-Unresponsive NMIBC

May 17, 2018

Novel immunotherapies and chemotherapies hold promise as non-surgical salvage options.

Bladder Cancer

Urinary Cytology and Biomarkers in NMIBC: What’s New?

Mohit Gupta, MD, and Trinity J. Bivalacqua, MD, PhD

April 16, 2018

Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance.

Next post in Bladder Cancer

Mohit Gupta, MD, and Trinity J. Bivalacqua, MD, PhD

All articles by Mohit Gupta, MD, and Trinity J. Bivalacqua, MD, PhD

Developments in the Management of BCG-Unresponsive NMIBC

Urinary Cytology and Biomarkers in NMIBC: What’s New?

Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer